Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RAB31 |
| Upstream (Parents) |
|---|
| (<<) MXRA8 → RAB31 |
| (<<) PMP22 → RAB31 |
| (<<) EFEMP2 → RAB31 |
| (<<) VIM → RAB31 |
| (<<) LGALS1 → RAB31 |
| (<<) MMP2 → RAB31 |
| Downstream (Children) |
|---|
| RAB31 → MXRA8 (>>) |
| RAB31 → PMP22 (>>) |
| RAB31 → TRPS1 (>>) |
| RAB31 → EMP3 (>>) |
| RAB31 → SLC1A3 (>>) |
| RAB31 → HS3ST3A1 (>>) |
| RAB31 → FCGR2A (>>) |
| RAB31 → VIM (>>) |
| RAB31 → CEP170 (>>) |
| RAB31 → SLFN12 (>>) |
| RAB31 → TM6SF1 (>>) |
| RAB31 → LGALS1 (>>) |
| RAB31 → HOXB2 (>>) |
| RAB31 → IFI16 (>>) |
| RAB31 → SYT11 (>>) |
| RAB31 → MFAP5 (>>) |
| RAB31 → TPSB2///TPSAB1 (>>) |
| RAB31 → MATN3 (>>) |
| RAB31 → CCL13 (>>) |
| RAB31 → TPSB2 (>>) |
| RAB31 → CPA3 (>>) |
| RAB31 → PDLIM4 (>>) |
| RAB31 → HSPB2 (>>) |
| RAB31 → PPEF1 (>>) |
| RAB31 → COLEC12 (>>) |
| RAB31 → MMP2 (>>) |
| RAB31 → ANTXR1 (>>) |
| RAB31 → CTSK (>>) |
| RAB31 → APBA2 (>>) |
| RAB31 → CCL8 (>>) |
| RAB31 → TNFSF12 (>>) |
| RAB31 → CLIP3 (>>) |
| RAB31 → OLFML2B (>>) |
| RAB31 → F13A1 (>>) |
| RAB31 → BCAT1 (>>) |
| RAB31 → SLAMF8 (>>) |
| RAB31 → DRAM1 (>>) |
